Medications

First biosimilar approved to treat multiple sclerosis

The U.S. Food and Drug Administration approved Tyruko (natalizumab-sztn), the first biosimilar to Tysabri (natalizumab) injection, for the treatment of relapsing forms of multiple sclerosis, the agency announced Thursday.

Medications

Study shows timing is key in cortisone treatment of inflammation

Whether you have a sports injury, repetitive strain injury or pain in the knee, cortisone preparations are often used to treat acute inflammations. Chronic inflammatory diseases such as asthma, diabetes and chronic inflammatory ...

Medications

Universal siRNA COVID-19 treatment shows promise in the lab

Lab data in cells has shown that siRNA has the potential to treat COVID-19 infection better than existing antivirals, according to new research from UNSW's Kirby and RNA Institutes, published today in Antiviral Research.

Neuroscience

Engineered probiotic developed to treat multiple sclerosis

Researchers from Brigham and Women's Hospital, a founding member of the Mass General Brigham health care system, have designed a probiotic to suppress autoimmunity in the brain, which occurs when the immune system attacks ...

page 19 from 40